Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaMarco L. Davila, Renier J. Brentjens, Isabelle Rivière et al.|Science Translational Medicine|2014Cited by 2.5k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONJoan Bladé, David H. Vesole, Diana Samson et al.|British Journal of Haematology|1998Cited by 1.5k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Robert H. Collins, John Nemunaitis, Ofer Shpilberg et al.|Journal of Clinical Oncology|1997Cited by 1.3k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative TherapySergio Giralt, Richard E. Champlin, Elihu H. Estey et al.|Blood|1997Cited by 1.2k
Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaPhilip L. McCarthy, Charles Linker, David D. Hurd et al.|New England Journal of Medicine|2012Cited by 1.1k